APA

Amirjanians M., Egemnazarov B., Sydykov A., Kojonazarov B., Brandes R., Luitel H., Pradhan K., Stasch J., Redlich G., Weissmann N., Grimminger F., Seeger W., Ghofrani H. & Schermuly R. (20180305). Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension. : Oncotarget.

Chicago

Amirjanians Matthieu, Egemnazarov Bakytbek, Sydykov Akylbek, Kojonazarov Baktybek, Brandes Ralf, Luitel Himal, Pradhan Kabita, Stasch Johannes-Peter, Redlich Gorden, Weissmann Norbert, Grimminger Friedrich, Seeger Werner, Ghofrani Hossein and Schermuly Ralph. 20180305. Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension. : Oncotarget.

Harvard

Amirjanians M., Egemnazarov B., Sydykov A., Kojonazarov B., Brandes R., Luitel H., Pradhan K., Stasch J., Redlich G., Weissmann N., Grimminger F., Seeger W., Ghofrani H. and Schermuly R. (20180305). Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension. : Oncotarget.

MLA

Amirjanians Matthieu, Egemnazarov Bakytbek, Sydykov Akylbek, Kojonazarov Baktybek, Brandes Ralf, Luitel Himal, Pradhan Kabita, Stasch Johannes-Peter, Redlich Gorden, Weissmann Norbert, Grimminger Friedrich, Seeger Werner, Ghofrani Hossein and Schermuly Ralph. Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension. : Oncotarget. 20180305.